COVAX — Columbia Small Cap Value and Inflection Fund
Data updated: 2026-07-29
COVAX — Columbia Small Cap Value and Inflection Fund data: holdings, portfolio allocation, expenses, performance, cashflows, risk and SEC filings. United States Small Cap Value Equity · $868.45M AUM · 1.20% expense ratio · 35.9% 1-yr return. From SEC regulatory filings.
COVAX Fund Overview
COVAX — Columbia Small Cap Value and Inflection Fund is a US mutual fund managed by Columbia Funds Series Trust, categorised as United States Small Cap Value Equity. ABC INVEST provides holdings, performance, costs, cashflows, risk data, prospectus documents and SEC filings, sourced from SEC filings.
- Type: US mutual fund
- Manager: Columbia Funds Series Trust
- Category: United States Small Cap Value Equity
- Assets under management: $868.45M
- 1-year return: 35.9%
- Ticker: COVAX
- SEC CIK: 0001097519
- SEC series ID: S000010793
- Share class ID: C000029855
COVAX Holdings
Top 10 holdings of Columbia Small Cap Value and Inflection Fund by percentage of net assets, from the fund's latest SEC N-PORT filing.
| Holding | % of net assets |
|---|---|
| Phillips Edison & Co Inc | 2.04% |
| StoneX Group Inc | 1.79% |
| Polaris Inc | 1.77% |
| Commercial Metals Co | 1.75% |
| BankUnited Inc | 1.70% |
| Texas Capital Bancshares Inc | 1.66% |
| Fulton Financial Corp | 1.62% |
| Synaptics Inc | 1.60% |
| Cabot Corp | 1.59% |
| Essent Group Ltd | 1.53% |
COVAX Portfolio Allocation
Asset-class allocation of Columbia Small Cap Value and Inflection Fund by percentage of net assets, from the latest SEC N-PORT filing.
| Asset class | Allocation |
|---|---|
| Equity | 98.8% |
| Cash & Equivalents | 1.1% |
COVAX Performance
Total returns for COVAX (as of 2026-08-01), from SEC filings.
| Period | Total return |
|---|---|
| YTD | 15.7% |
| 1 year | 35.9% |
| 3 years (annualised) | 17.7% |
| 5 years (annualised) | 7.4% |
COVAX Risk Information
Risk metrics for COVAX, derived from monthly returns in SEC filings.
- 1-year volatility (annualised): 12.8%
COVAX Costs and Fees
COVAX costs about $120 per $10,000 invested per year in fund expenses.
- Net expense ratio: 1.20%
- Gross expense ratio: 1.37%
- Portfolio turnover: 115%
- Brokerage commissions: 16.06 bps of average net assets (SEC N-CEN)
COVAX Cashflows
Over the 12 months to 2026-02, Columbia Small Cap Value and Inflection Fund had net outflows of $82.36M, from monthly SEC N-PORT filings.
| Month | Net flow |
|---|---|
| 2026-02 | −$8.71M |
| 2026-01 | −$27.44M |
| 2025-12 | $49.51M |
| 2025-11 | −$22.41M |
| 2025-10 | −$14.73M |
| 2025-09 | −$41.73M |
COVAX Debt Constituents
No individual debt constituents are reported in Columbia Small Cap Value and Inflection Fund's latest SEC N-PORT filing.
COVAX Prospectus and SEC Filings
Official Columbia Small Cap Value and Inflection Fund filings on SEC EDGAR — prospectus, portfolio holdings and annual reports.
Related Funds
Other United States Small Cap Value Equity funds tracked on ABC INVEST:
Data Sources
ABC INVEST compiles this page from public filings made to the U.S. Securities and Exchange Commission (SEC) through EDGAR: portfolio holdings and monthly cashflows from Form N-PORT, expenses and returns from fund prospectuses (Form 485BPOS) and the SEC DERA Risk/Return Summary data sets, annual data from Form N-CEN, and shareholder reports from Form N-CSR.